What conditions are being studied for psychedelic treatment?

Psychedelics are being studied for conditions including chronic Lyme disease, Alzheimer's disease, anorexia nervosa, chronic back pain, obsessive compulsive disorder, and post-traumatic stress disorder.

What is the debate surrounding psychedelic therapy benefits?

The debate centers on whether the benefits of psychedelic therapy stem from the drug's effect on brain chemistry or the profound personal, transformative experiences patients undergo during the journey.

Why is psychedelic research being revived now?

Research is being revived due to the limitations of existing treatments like SSRIs, which do not work for everyone, and the success of other rapid-acting treatments like ketamine, creating a need for alternative mental health therapies.

Home / Health / Psychedelics: Mind vs. Medicine?

Psychedelics: Mind vs. Medicine?

13 Mar

•

Summary

Psychedelics are studied for chronic Lyme, Alzheimer's, and PTSD.
Lyme patient felt significant improvement after psilocybin treatment.
Scientists debate if drug effects stem from brain chemistry or experience.

Psychedelics, such as psilocybin from magic mushrooms, are under investigation for treating a wide array of conditions, including chronic Lyme disease, Alzheimer's, and PTSD. Albert Garcia-Romeu, a psychologist at Johns Hopkins University, led a study on psilocybin for post-Lyme disease patients.

One patient, Lori Unruh Snyder, a professor, experienced significant psychological symptoms even after antibiotic treatment for Lyme disease. After participating in the psilocybin study, she reported a transformative shift in her perspective and teaching methods, referring to herself as a 'new Lori.'